Detalhe da pesquisa
1.
Isolated Extramedullary Relapse as a Poor Predictor of Survival after Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia.
Biol Blood Marrow Transplant
; 25(9): 1756-1760, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31128329
2.
Long-term outcomes of total body irradiation plus cyclophosphamide versus busulfan plus cyclophosphamide as conditioning regimen for acute lymphoblastic leukemia: a comparative study.
Ann Hematol
; 97(10): 1987-1994, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-29869673
3.
In vitro evidence of complement activation in patients with sickle cell disease.
Haematologica
; 102(12): e481-e482, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28912175
4.
Left Atrial Strain Identifies Increased Atrial Ectopy in Patients with Beta-Thalassemia Major.
Diagnostics (Basel)
; 11(1)2020 Dec 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33375056
5.
Beta-thalassemia: renal complications and mechanisms: a narrative review.
Hematology
; 24(1): 426-438, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30947625
6.
Carmustine, etoposide, cytarabine and melphalan versus a newly designed intravenous busulfan-based Busulfex, etoposide and melphalan conditioning regimen for autologous hematopoietic cell transplant: a retrospective matched-pair analysis in advanced Hodgkin and non-Hodgkin lymphomas.
Leuk Lymphoma
; 56(11): 3071-81, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25760637
7.
Pre- and Post-transfusion Complement Activation in Transfusion-dependent ß-thalassaemia.
Hemasphere
; 2(5): e58, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30887002